Structural insight into equine lentivirus receptor 1

Area of Science:

• Structural biology
• Virology
• Molecular interactions

Background:

• Equine infectious anemia virus (EIAV) is a significant pathogen in horses.
• Equine lentivirus receptor 1 (ELR1) is a known cellular receptor for EIAV.
• Understanding the molecular basis of EIAV entry is crucial for developing antiviral strategies.

Purpose of the Study:

• To determine the structure of equine lentivirus receptor 1 (ELR1).
• To investigate the interaction between ELR1 and the EIAV surface glycoprotein gp90.
• To identify critical residues involved in the ELR1-gp90 binding.

Main Methods:

• Recombinant expression and purification of ELR1 and gp90.
• Analytical ultracentrifugation (AUC) for complex stoichiometry determination.
• X-ray crystallography for ELR1 structure determination.
• Isothermal titration calorimetry (ITC) for binding analysis.

Main Results:

• ELR1 and gp90 exist as monomers in solution and form a 1:1 complex.
• The crystal structure of ELR1 was determined, revealing eight antiparallel β-sheets across its domains.
• Specific residues (Tyr61, Leu70, Gly72) in CRD1 of ELR1 were identified as important for gp90 binding.
• ITC confirmed Leu70 and Gly72 as critical for this interaction.

Conclusions:

• The study provides the first structural determination of ELR1.
• Key residues mediating the interaction between ELR1 and EIAV gp90 have been identified.
• This structural and biochemical data offers insights into EIAV entry mechanisms and potential therapeutic targets.